BioAsia is an international business convention promoted by the Government of Telangana in partnership with the Government of India and the Federation of Asian Biotech Associations.
The group has four subsidiary companies- Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant Food Works Limited and Jubilant Industries Limited.
Jubilant Bhartia Group will set up a state-of-the-art facility in Hyderabad’s Genome Valley.
The Noida-headquartered conglomerate announced its new centre on the sidelines of the 20th edition of the BioAsia Business Convention.
Genome Valley is a hub of prominent Indian and global pharma companies and renowned R&D organisations. It is home to more than 200 companies, including Novartis, Ferring Pharma, Chemo, DuPont, and Ashland. It has a workforce of around 15,000 professionals.
Jubilant Bhartia is active in sectors such as pharmaceuticals, contract research, and development services, proprietary novel drugs, life science ingredients, agricultural products, performance polymers, food services, and consulting in aerospace and oilfield services.
The group has four subsidiary companies: Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant Food Works Limited and Jubilant Industries Limited. It has around 46,000 employees globally.
Jubilant Bhartia Group, a global leader in Pharma & Life Science announced to establish a state-of-the-art facility in Genome Valley, Hyderabad
The announcement was made after Hari S Bhartia, Founder & Co-Chairman, JB Pharma met Minister @KTRBRS on the sidelines of #BioAsia2023 pic.twitter.com/tFbLxx3Hnp
— KTR, Former Minister (@MinisterKTR) February 25, 2023
Expressing delight over the firm’s decision, Telangana’s IT & Urban Affairs Minister KT Rama Rao said, “Jubilant’s entry is a testament to the city’s vibrant ecosystem, extraordinary infrastructure, and rich talent pool that drives innovation.”
“With the entry of Jubilant, Hyderabad will host all major CROs (Clinical Research Organisations) in India and the city has emerged as the Lifesciences Research Capital,” the minister added.
He promised the government’s “full support and cooperation” to the group to help it grow organically in the state.
Founder and Co-Chairman of the Jubilant Bhartia Group Hari S Bhartia said that Hyderabad has over the years become a centre for biotechnology and life sciences, bringing in a great deal of investment from industry.
“It provides a favourable ecosystem for developing biotechnology and life sciences businesses, with a wide variety of qualified talent pools, world-class infrastructure, and business-friendly government,” he stated.
He added that Jubilant Biosys will explore the possibility of setting up a state-of-the-art facility in Genome Valley in near future.
Biosys provides “comprehensive” drug discovery services and contract research services from target discovery to candidate selection with flexible business models. It is done in partnership with leading global healthcare providers.
May 02, 2024
May 02, 2024
Apr 29, 2024
Apr 27, 2024
Apr 25, 2024
Apr 23, 2024
